The market has been quite volatile in recent years, with the S&P 500 and Nasdaq Composite showing strong gains. The performance of your portfolio depends on the stocks you choose, as some may lag behind due to investor sentiment.
Two companies worth considering are Pfizer (NYSE: PFE) and Chewy (NYSE: CHWY). Pfizer has seen a decline in its stock price, but has made strategic acquisitions to boost its oncology portfolio. The company is poised for growth in the coming years, with a focus on biologics in the oncology market.
Chewy, on the other hand, has shown profitability and strong growth figures. Despite concerns about discretionary spending, the pet market is growing steadily, providing a stable revenue stream for Chewy. The company has diversified revenue streams and could be a good investment opportunity.
Before investing in Pfizer, it’s important to consider other potential stocks for growth. The Motley Fool Stock Advisor team has identified 10 top stocks that could yield significant returns in the future. Their recommendations have outperformed the S&P 500 since 2002, making it a valuable resource for investors.
In conclusion, both Pfizer and Chewy offer growth potential for investors looking for opportunities under $100. It’s important to do thorough research and consider all options before making any investment decisions.